microdosing tirzepatide for autoimmune Can Microdose GLP-1 Agonists Help Disease? Microdosing GLP-1: What to Know

However, this is also when the medication starts working at full capacity

The two peptides act on entirely different receptors, making combination use mechanistically rational, but human RCT evidence for the specific combination is absent

Both medications cause slow gastric emptying, which can cause vomiting, nausea, and digestive discomfort

This might be a healthcare provider, a registered dietitian, a therapist who specializes in eating behavior, or a peer community of others navigating the same transition

However, continuing treatment beyond one year is typically safe and can further assist in weight maintenance